Literature DB >> 29113260

Expression of c-Met and hepatocyte growth factor in various gastric pathologies and its association with Helicobacter pylori infection.

Chuan Xie1, Zhen Yang1, Yi Hu1, Ximei Cao1, Jiang Chen1, Yin Zhu1, Nonghua Lu1.   

Abstract

Activation of the hepatocyte growth factor (HGF)/c-Met signaling pathway was identified to be associated with malignant tumors. The present study aimed at determining the expression of HGF and c-Met in gastric carcinogenesis and its association with Helicobacter pylori infection. Gastric biopsies were obtained from 160 H. pylori-negative and -positive patients, including those with chronic gastritis, intestinal metaplasia, dysplasia and gastric cancer (GC). Proteins were extracted from GES-1, gastric epithelial, and AGS, gastric adenocarcinoma, cells following co-culture with H. pylori in vitro. The expression of HGF and c-Met in gastric tissues or cells was determined using immunohistochemistry and western blot analysis. The expression of c-Met increased in GC tissues (72.5%) compared with that in pre-cancerous lesions (17.5, 17.5 and 30%). Additional analysis identified that the expression of HGF and c-Met was significantly increased in the presence of H. pylori infection in dysplasia and gastric cancer samples. Furthermore, H. pylori may activate the HGF/c-Met signaling pathway in vitro, which may contribute to gastric carcinogenesis.

Entities:  

Keywords:  Helicobacter pylori; c-Met; gastric cancer; hepatocyte growth factor

Year:  2017        PMID: 29113260      PMCID: PMC5661599          DOI: 10.3892/ol.2017.6983

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  16 in total

1.  The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas.

Authors:  M Nakajima; H Sawada; Y Yamada; A Watanabe; M Tatsumi; J Yamashita; M Matsuda; T Sakaguchi; T Hirao; H Nakano
Journal:  Cancer       Date:  1999-05-01       Impact factor: 6.860

Review 2.  Hepatocyte growth factor--scatter factor: mitogen, motogen, and met.

Authors:  E Gherardi; M Stoker
Journal:  Cancer Cells       Date:  1991-06

Review 3.  Epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions in the colon.

Authors:  Ferenc Sipos; Orsolya Galamb
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

4.  c-Met expression in gastric cancer with liver metastasis.

Authors:  Hideki Amemiya; Koji Kono; Jun Itakura; Rui Feng Tang; Akihiro Takahashi; Feng-Qi An; Shigeo Kamei; Hidehiko Iizuka; Hideki Fujii; Yoshiro Matsumoto
Journal:  Oncology       Date:  2002       Impact factor: 2.935

Review 5.  Helicobacter pylori and gastric cancer: factors that modulate disease risk.

Authors:  Lydia E Wroblewski; Richard M Peek; Keith T Wilson
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 6.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.

Authors:  M F Dixon; R M Genta; J H Yardley; P Correa
Journal:  Am J Surg Pathol       Date:  1996-10       Impact factor: 6.394

Review 7.  HGF/MET signaling in ovarian cancer.

Authors:  Hong Yan Zhou; Yuen Lam Pon; Alice S T Wong
Journal:  Curr Mol Med       Date:  2008-09       Impact factor: 2.222

8.  Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response.

Authors:  Yuri Churin; Laila Al-Ghoul; Oliver Kepp; Thomas F Meyer; Walter Birchmeier; Michael Naumann
Journal:  J Cell Biol       Date:  2003-04-28       Impact factor: 10.539

9.  Host-pathogen systems biology: logical modelling of hepatocyte growth factor and Helicobacter pylori induced c-Met signal transduction.

Authors:  Raimo Franke; Melanie Müller; Nicole Wundrack; Ernst-Dieter Gilles; Steffen Klamt; Thilo Kähne; Michael Naumann
Journal:  BMC Syst Biol       Date:  2008-01-14

Review 10.  HGF/MET-directed therapeutics in gastroesophageal cancer: a review of clinical and biomarker development.

Authors:  Stephen P Hack; Jean-Marie Bruey; Hartmut Koeppen
Journal:  Oncotarget       Date:  2014-05-30
View more
  4 in total

1.  Study on the expression of c-Met in gastric cancer and its correlation with preoperative serum tumor markers and prognosis.

Authors:  Zhengchao Zhang; Lele Miao; Song Wang; Yang Zhao; Yongqiang Xie; Heng Yun; Zhijian Ren; Guan Wang; Muzhou Teng; Yumin Li
Journal:  World J Surg Oncol       Date:  2022-06-16       Impact factor: 3.253

2.  Effect of fluorouracil, leucovorin, and oxaliplatin with or without onartuzumab in epidermal growth factor receptor-2-negative, mesenchymal-epithelial transition-positive gastroesophageal adenocarcinoma: is it a real failure?

Authors:  Jimmy T Efird; Charulata Jindal; Timothy Fitzgerald; Tithi Biswas
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-07

Review 3.  Tyrosine Kinases in Helicobacter pylori Infections and Gastric Cancer.

Authors:  Bianca E Chichirau; Sebastian Diechler; Gernot Posselt; Silja Wessler
Journal:  Toxins (Basel)       Date:  2019-10-11       Impact factor: 4.546

4.  Transcriptome Analysis of the Inhibitory Effect of Astaxanthin on Helicobacter pylori-Induced Gastric Carcinoma Cell Motility.

Authors:  Suhn Hyung Kim; Hyeyoung Kim
Journal:  Mar Drugs       Date:  2020-07-15       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.